⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Chronic Lower Back Pain Market Forecast, 2036 | Industry Set for Steady Growth as Regenerative Medicine and Opioid Alternatives Drive Innovation
globenewswire.com
LLY
VRTX
MESO
2026 Obstructive Sleep Apnea (OSA) Competitive Landscape and Clinical Trial Analysis - 18+ Companies Advance New OSA Therapies
globenewswire.com
LLY
APMD
AMGN
NVO
Form 8-K
sec.gov
SGMOQ
LLY
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
globenewswire.com
ALGT
PHG
MASS
WMT
MDLZ
SSTK
SMCI
NVDA
MSFT
GOOG
AMZN
META
IBM
CRM
ADBE
INTC
AMD
MU
QCOM
PANW
SNPS
CDNS
ASML
AMAT
LRCX
KLAC
TER
NXPI
ON
AEHR
PLTR
AI
UPST
SOFI
COIN
MARA
RIOT
PLUG
FCEL
BE
EXAS
REGN
GILD
BIIB
CRSP
ROKU
NFLX
DIS
CMCSA
TTD
SNOW
DDOG
ZS
CRWD
OKTA
SMTC
MCHP
ADI
TXN
MRVL
ALGN
CTAS
PAYX
ADP
CVS
UNH
AMGN
LLY
PFE
MRK
JNJ
BMY
ABBV
VRTX
AZN
NVO
SNY
XOM
CVX
SRE
NEE
DUK
SO
PCG
ED
AEP
ETR
WEC
D
NI
EXC
NRG
CEG
IRBT
GOOGL
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
globenewswire.com
ABBV
LLY
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
globenewswire.com
ABBV
LLY
AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15
accessnewswire.com
LLY
Assessment of the Rheumatoid Arthritis Market 2026-2036 Featuring Rise Therapeutics, Taiho Pharmaceutical, Abbvie, Eli Lilly/Incyte, and AstraZeneca
globenewswire.com
ABBV
LLY
INCY
AZN
REGN
SNY
PFE
Commercial Assessment of the Chronic Kidney Disease (CKD) Market 2026-2036: Diagnosis Rates Rise and Treatment Options Expand
globenewswire.com
LLY
AZN
Commercial Assessment of the Diabetic Nephropathy Market 2026-2036 Featuring Boehringer Ingelheim, Eli Lilly, Bayer, AstraZeneca, UCB Biopharma, Serodus, and Palatin
globenewswire.com
LLY
AZN
PTN